Clinical Observation of Shengmaisan Combined with Polymyxin B in Treatment of Sepsis Complicated with Severe Acute Respiratory Distress Syndrome
|更新时间:2024-06-18
|
Clinical Observation of Shengmaisan Combined with Polymyxin B in Treatment of Sepsis Complicated with Severe Acute Respiratory Distress Syndrome
“The latest research has found that the combination of Shengmai San and polymyxin B can effectively eliminate pathogenic bacteria, control infection, reduce levels of inflammatory factors, regulate immune status, and improve short-term prognosis in the treatment of carbapenem resistant gram-negative bacterial sepsis with severe acute respiratory distress syndrome.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 12, Pages: 129-135(2024)
ZHANG Yu,CHEN Qingfeng,YIN Xi,et al.Clinical Observation of Shengmaisan Combined with Polymyxin B in Treatment of Sepsis Complicated with Severe Acute Respiratory Distress Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(12):129-135.
ZHANG Yu,CHEN Qingfeng,YIN Xi,et al.Clinical Observation of Shengmaisan Combined with Polymyxin B in Treatment of Sepsis Complicated with Severe Acute Respiratory Distress Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(12):129-135. DOI: 10.13422/j.cnki.syfjx.20232226.
Clinical Observation of Shengmaisan Combined with Polymyxin B in Treatment of Sepsis Complicated with Severe Acute Respiratory Distress Syndrome